HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

MTLS

Materialise NV (NASDAQ)

Technology — Software - Application

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

None 3 analysts
$7.11
$-0.32 (-4.31%)
Target: $8.11 (14.0%)
Sign in to add MTLS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$412.87M
P/E Ratio (TTM)37.42
Forward P/E25.12
EPS (TTM)$0.19
Dividend Yield-
Profit Margin3.76%
Revenue Growth-0.20%
ROE3.99%
Debt/Equity23.52
Recommendation None
Analyst Target$8.11
Analysts3
Indexes NASDAQ

Technical Indicators

RSI (14)65.7
Beta1.35
SMA 20-
SMA 40-
52-Week High$7.50
52-Week Low$4.78
50-Day Avg$6.14
200-Day Avg$5.74
Avg Volume132.8K
Volume142.6K

Performance Analysis

BULLISH

MTLS shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 86% of its 52-week range.
+ RSI at 65.7 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- Revenue declined 0.2% year-over-year.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $8.11 implies 14.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:21 UTC

Back to Screener Export Report